Recombinant CLDN18.2 (Zolbetuximab Biosimilar) antibody

Catalog No. ABIN7487777

This Mammalian Cells Monoclonal antibody specifically detects CLDN18.2 (Zolbetuximab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant CLDN18.2 (Zolbetuximab Biosimilar) antibody (ABIN7487777)

Target: CLDN18.2 (Zolbetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This CLDN18.2 (Zolbetuximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CLDN18.2 (Zolbetuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Zolbetuximab Biosimilar - Anti-CLDN18.2 mAb

Characteristics: Antibody Type: IgG1

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1, IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for CLDN18.2 (Zolbetuximab Biosimilar)

Target: CLDN18.2 (Zolbetuximab Biosimilar)

Target Type: Biosimilar

Background: Zolbetuximab